B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies.

Authors: Rahaf Omaish, Carolina D. Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19540

Source: Full article

---

Abstract

e19540